Skip to main content
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 19, 2014; 83 (8) Clinical Implications of Neuroscience Research

Dopamine receptor signaling in the forebrain

Recent insights and clinical implications

Rodolfo Savica, Eduardo E. Benarroch
First published July 18, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000719
Rodolfo Savica
From the Sleep and Movement Disorders Division (R.S.), Department of Neurology, University of Utah, Salt Lake City; and the Department of Neurology (E.E.B.), Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo E. Benarroch
From the Sleep and Movement Disorders Division (R.S.), Department of Neurology, University of Utah, Salt Lake City; and the Department of Neurology (E.E.B.), Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Dopamine receptor signaling in the forebrain
Recent insights and clinical implications
Rodolfo Savica, Eduardo E. Benarroch
Neurology Aug 2014, 83 (8) 758-767; DOI: 10.1212/WNL.0000000000000719

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
565

Share

  • Article
  • Figures & Data
  • Info & Disclosures
  • CME Course
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Dopamine (DA) is an important modulator of neuronal activity and synaptic plasticity throughout the CNS. The actions of DA are mediated by D1- and D2-type receptors, which are distributed presynaptically, postsynaptically, and extrasynaptically, in projection and interneurons. These receptors utilize phosphorylation cascades or direct membrane interactions to affect the function of voltage- and neurotransmitter-gated channels, cytosolic enzymes, and transcription factors. Via these mechanisms, DA receptors have complex effects on neurotransmitter release, neuronal excitability, synaptic integration, synaptic plasticity, and circuit interactions. D1- and D2-type receptors may also form complexes with each other and with other receptors, which adds to the complexity and flexibility of dopaminergic signaling. In the CNS, DA receptors are primarily distributed in the striatum and frontal cortex, where they affect action selection, exertion of effort, attention and working memory, behavioral activation, and learning from both rewarding and aversive events. Abnormal DA signaling in these circuits is associated with Parkinson disease (PD), dystonia, schizophrenia, drug addiction, and attention-deficit disorders. The manifestations of these conditions reflect both the direct effects of impaired DA receptor signaling and DA receptor-triggered plastic changes in striatal and cortical synapses. The physiology, signaling, and pharmacology of DA receptors and their involvement in disease have been the subject of several reviews.1–8

Footnotes

  • Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • © 2014 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • GLOSSARY
    • OVERVIEW OF THE MIDBRAIN DOPAMINERGIC SYSTEM
    • CLASSIFICATION AND DISTRIBUTION OF DA RECEPTORS
    • TRANSDUCTION SIGNALS AND SYNAPTIC EFFECTS OF DA RECEPTORS
    • EFFECTS OF DA IN FOREBRAIN CIRCUITS
    • CLINICAL IMPLICATIONS
    • PERSPECTIVE
    • STUDY FUNDING
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
  • CME Course

More Online

CME Course

Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension

Dr. Deborah Friedman and Dr. Stacy Smith

► Watch

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Clinical Implications of Neuroscience Research
    Intrinsic circuits of the striatum
    Complexity and clinical correlations
    Eduardo E. Benarroch et al.
    Neurology, March 23, 2016
  • Clinical Implications of Neuroscience Research
    Heterogeneity of the midbrain dopamine system
    Implications for Parkinson disease
    Anhar Hassan, Eduardo E. Benarroch et al.
    Neurology, October 16, 2015
  • Articles
    In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias
    N. Turjanski, A. J. Lees, D. J. Brooks et al.
    Neurology, September 01, 1997
  • Clinical Implications of Neuroscience Research
    Effects of acetylcholine in the striatum
    Recent insights and therapeutic implications
    Eduardo E. Benarroch et al.
    Neurology, July 16, 2012
Neurology: 101 (7)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise